
Credit: NIAID
Fluorescent microscopy image showing accumulation of phosphatidylethanolamine (PE, red) in human dendritic cells treated with synthetic F. tularensis PE containing liposomes. Blue indicates the cell nucleus
NIH Scientists See Therapeutic Potential Against Bacteria, Viruses
National Institutes of Health researchers have identified a naturally occurring lipid—a waxy, fatty acid—used by a disease-causing bacterium to impair the host immune response and increase the chance of infection. Inadvertently, they also may have found a potent inflammation therapy against bacterial and viral diseases.
Lipids are known to help Francisella tularensis bacteria, the cause of tularemia, to suppress host inflammation when infecting mouse and human cells. In a new study published in the Journal of Innate Immunity, researchers from NIH’s National Institute of Allergy and Infectious Diseases found a form of the lipid phosphatidylethanoloamine, or PE, present in the bacterium. The composition of PE found in F. tularensis differs from PE found in other bacteria. In cell-culture experiments, the researchers discovered that the natural and a synthetic form of PE reduced inflammation caused by both tularemia bacteria and dengue fever virus.
Tularemia is a life-threatening disease spread to humans via contact with an infected animal or through the bite of a mosquito, tick or deer fly. Although tularemia can be successfully treated with antibiotics, it is difficult to diagnose, mainly because F. tularensis bacteria can suppress the human immune response. Dengue fever, primarily spread by Aedes aegypti mosquitoes, is rarely fatal but usually leads to a high fever, severe headache and pain throughout the body. There is no specific treatment for dengue fever.
After identifying PE as the lipid that impaired the immune response, the scientists began to consider its potential therapeutic value. Because natural F. tularensis is highly infectious and therefore challenging to work with, the group developed synthetic lipids—PE2410 and PEPC2410—that would be much easier to study and produce. They then verified that both synthetic lipids also suppressed the immune response during infection of mouse and human cells in the laboratory.
Because several types of viral infections involve an unconstrained inflammatory response, the group tested natural and their synthetic PE in the laboratory against dengue fever virus-infected human cells. Both versions inhibited the immune response compared to the immune response seen in infected but untreated cells.
The group plans to continue exploring how F. tularensis impairs the immune response. They hope their findings will eventually lead to the development of a potent, broad-spectrum anti-inflammatory therapeutic.
Learn more: Natural Lipid Acts as Potent Anti-Inflammatory
The Latest on: Inflammation therapy
[google_news title=”” keyword=”inflammation therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Inflammation therapy
- Atopic dermatitis: Viruses discovered as new therapy optionon October 1, 2023 at 5:06 pm
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, ...
- Why CAR-T cell therapy is the cancer killer the world needs nowon September 30, 2023 at 5:00 am
The rising cancer treatment and technology known as CAR-T uses a patient’s own blood cells to cure their malignancies.
- Chronic Back Pain May Be Eased With a Type of Talk Therapy, Study Findson September 28, 2023 at 7:36 am
New research shows that people with chronic back pain who underwent pain reprocessing therapy (PRT) were more likely after treatment to see their pain as stemming from their mind or brain.
- How Stress Can Impact Inflammatory Bowel Diseaseon September 28, 2023 at 3:30 am
This News Feature explores the role of psychological stress in exacerbating inflammatory bowel disease, and offers ...
- Yeast in the gut linked to Crohn's disease inflammation, opening new doors for treatmenton September 27, 2023 at 8:26 pm
New study in Nature Medicine links yeast cells in the gastrointestinal tract to abnormal immune responses causing inflammation in Crohn's disease patients. The research suggests that these ...
- MLS laser therapy offers alternative to invasive treatments at Upstate chiropractic clinicon September 26, 2023 at 1:53 pm
Advanced Chiropractic of South Carolina in Greenville is one of less than five clinics in the state offering MLS laser therapy ...
- Light therapy helps the brain clear out toxic Alzheimer’s proteinson September 24, 2023 at 10:51 pm
A new study has found that light therapy applied to mice during deep sleep increased the brain’s ability to clear away beta-amyloid, a toxic protein linked to the development of Alzheimer’s disease.
- What to know about inflammation of the adrenal glandson September 23, 2023 at 5:00 pm
Adrenal insufficiency is another potential cause of adrenal gland inflammation. Treatments for adrenal insufficiency may include hormone therapy or, in rare cases, surgery. Anyone experiencing new ...
- Study Finds Systemic Postoperative Inflammation Contributes to Worsened Patient Outcomeson September 21, 2023 at 9:38 am
Persistent disability and risks of death were associated with inflammatory levels in patients following major abdominal surgery.
via Bing News